1-3 of 3
Miguel Villalona-Calero, MD
Close
Sort by
Journal Articles

Quantification of the Active Decitabine-Triphosphate (DAC-TP) Metabolite: A Novel Pharmacoanalytical Endpoint for Optimization of Hypomethylating Therapy in Acute Myeloid Leukemia (AML)

Hongyan Wang, Ping Chen, Ph.D., Jiang Wang, Ramasamy Santhanam, Ph.D, Josephine Aimiuwu, Vijayasaradhi UV, Zhongfa Liu, Sebastian Schwind, MD, Alice S. Mims, MD, Rebecca B Klisovic, MD, Alison Walker, MD, Michael R. Grever, MD, Miguel Villalona-Calero, MD, John C. Byrd, MD, Ramiro Garzon, MD, William Blum, MD, Kenneth K. Chan, Ph.D, Guido Marcucci, MD
Journal: Blood
Blood (2012) 120 (21): 3578.
https://doi.org/10.1182/blood.V120.21.3578.3578
Published: 2012
Journal Articles

Risk Factors for Tumor Lysis Syndrome (TLS) In Patients with Chronic Lymphocytic Leukemia (CLL) Treated with the Cyclin Dependent Kinase Inhibitor, Flavopiridol.

Kristie A. Blum, MD, Amy S. Ruppert, Jennifer A. Woyach, MD, Jeffrey A. Jones, MD, MPH, Leslie Andritsos, MD, Joseph M. Flynn, DO, MPH, Brad Rovin, MD, Miguel Villalona-Calero, MD, Jia Ji, Mitchell Phelps, PhD, Amy J. Johnson, PhD, Michael R. Grever, M.D., John C. Byrd, MD
Journal: Blood
Blood (2010) 116 (21): 1386.
https://doi.org/10.1182/blood.V116.21.1386.1386
Published: 2010
Journal Articles

Preliminary Results of a Phase II Study of Low Dose Decitabine as a Single Agent in Older Patients (ageā‰„60) with Previously Untreated Acute Myeloid Leukemia (AML)

William Blum, MD, Rebecca Klisovic, MD, Shujun Liu, PhD, Ramiro Garzon, MD, Cheryl Kefauver, RN, Zhongfa Liu, PhD, Jon Mickle, CNP, Hollie Devine, CNP, Steve Devine, MD, Michael R Grever, MD, Kenneth K Chan, PhD, Miguel Villalona-Calero, MD, John C. Byrd, MD, Guido Marcucci, MD
Journal: Blood
Blood (2008) 112 (11): 2957.
https://doi.org/10.1182/blood.V112.11.2957.2957
Published: 2008